MedRx Co., Ltd (TYO:4586)

Japan · Delayed Price · Currency is JPY

65.00

0.00 (0.00%)

May 29, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development of Pharmaceutical Formulations and Ancillary Operations	128.00M	257.00M	29.00M	59.00M	8.00M
Development of Pharmaceutical Formulations and Ancillary Operations Growth	-50.19%	786.21%	-50.85%	637.50%	-93.04%
Total	128.00M	257.00M	29.00M	59.00M	8.00M
Total Growth	-50.19%	786.21%	-50.85%	637.50%	-93.04%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan	103.98M	325.00K	29.00M	59.00M	8.00M
Japan Growth	31892.62%	-98.88%	-50.85%	637.50%	-93.04%
United States of America	24.11M	257.59M	-	-	-
United States of America Growth	-90.64%	-	-	-	-
Total	128.08M	257.91M	29.00M	59.00M	8.00M
Total Growth	-50.34%	789.36%	-50.85%	637.50%	-93.04%

Source: S&P Global Market Intelligence.